Leerink Partnrs Lowers Earnings Estimates for agilon health

agilon health, inc. (NYSE:AGL) – Equities research analysts at Leerink Partnrs decreased their FY2024 EPS estimates for shares of agilon health in a research note issued on Monday, November 11th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of ($0.65) for the year, down from their prior forecast of ($0.35). The consensus estimate for agilon health’s current full-year earnings is ($0.35) per share. Leerink Partnrs also issued estimates for agilon health’s Q4 2024 earnings at ($0.27) EPS, Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.19) EPS, Q4 2025 earnings at ($0.20) EPS, FY2025 earnings at ($0.39) EPS, FY2026 earnings at ($0.26) EPS, FY2027 earnings at ($0.18) EPS and FY2028 earnings at ($0.07) EPS.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the previous year, the business posted ($0.06) EPS.

A number of other research analysts have also commented on the company. Citigroup lowered their price target on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a report on Wednesday. Barclays lowered their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday. Evercore ISI reduced their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research note on Wednesday, October 2nd. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $8.00 target price on shares of agilon health in a research report on Wednesday, August 7th. Three equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $6.38.

agilon health Stock Down 8.5 %

AGL opened at $1.72 on Thursday. The stock’s 50 day moving average price is $3.14 and its 200 day moving average price is $4.90. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The stock has a market cap of $708.67 million, a P/E ratio of -2.01 and a beta of 0.60. agilon health has a 12 month low of $1.70 and a 12 month high of $13.76.

Insider Activity

In other news, CEO Steven Sell bought 20,000 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This represents a 42.03 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. 3.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On agilon health

Several hedge funds have recently made changes to their positions in AGL. J.Safra Asset Management Corp raised its stake in agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the period. City State Bank acquired a new position in agilon health during the third quarter valued at $52,000. CWM LLC raised its position in agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after buying an additional 7,288 shares during the period. Nisa Investment Advisors LLC purchased a new stake in agilon health in the 2nd quarter worth about $60,000. Finally, Bleakley Financial Group LLC acquired a new stake in agilon health during the 1st quarter worth about $65,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.